Drug
Tramadol Hydrochloride Dexketoprofen Trometamol
Tramadol Hydrochloride Dexketoprofen Trometamol: highest development phase Post-Market, developed by Menarini. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tramadol Hydrochloride/Dexketoprofen Trometamol NCT02777970 | Post-Market | Acute Pain |
Latest
No recent events.
Follow Tramadol Hydrochloride Dexketoprofen Trometamol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.